Raymond James Financial’s ImmunityBio IBRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$404K	Buy	153,060 +68,956	+82%	+$182K	﹤0.01%	4107
2025 Q1	$253K	Buy	84,104 +16,750	+25%	+$50.4K	﹤0.01%	4265
2024 Q4	$172K	Buy	+67,354	New	+$172K	﹤0.01%	4402